rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis

por Derkaev, Artem A., Ryabova, Ekaterina I., Esmagambetov, Ilias B., Shcheblyakov, Dmitry V., Godakova, Svetlana A., Vinogradova, Irina D., Noskov, Anatoly N., Logunov, Denis Y., Naroditsky, Boris S., Gintsburg, Alexander L.
Publicado 2022

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

por Esmagambetov, Ilias B., Ryabova, Ekaterina I., Derkaev, Artem A., Shcheblyakov, Dmitry V., Dolzhikova, Inna V., Favorskaya, Irina A., Grousova, Daria M., Dovgiy, Mikhail A., Prokofiev, Vladimir V., Gosudarev, Andrey I., Byrikhina, Daria V., Zorkov, Ilia D., Iliukhina, Anna A., Kovyrshina, Anna V., Shelkov, Artem Y., Naroditsky, Boris S., Logunov, Denis Y., Gintsburg, Alexander L.
Publicado 2023

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A

por Panova, Eugenia A., Kleymenov, Denis A., Shcheblyakov, Dmitry V., Bykonia, Evgeniia N., Mazunina, Elena P., Dzharullaeva, Alina S., Zolotar, Anastasia N., Derkaev, Artem A., Esmagambetov, Ilias B., Sorokin, Ivan I., Usachev, Evgeny V., Noskov, Anatoly N., Ivanov, Igor A., Zatsepin, Timofei S., Dmitriev, Sergey E., Gushchin, Vladimir A., Naroditsky, Boris S., Logunov, Denis Y., Gintsburg, Alexander L.
Publicado 2023

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

por Favorskaya, Irina A., Shcheblyakov, Dmitry V., Esmagambetov, Ilias B., Dolzhikova, Inna V., Alekseeva, Irina A., Korobkova, Anastasia I., Voronina, Daria V., Ryabova, Ekaterina I., Derkaev, Artem A., Kovyrshina, Anna V., Iliukhina, Anna A., Botikov, Andrey G., Voronina, Olga L., Egorova, Daria A., Zubkova, Olga V., Ryzhova, Natalia N., Aksenova, Ekaterina I., Kunda, Marina S., Logunov, Denis Y., Naroditsky, Boris S., Gintsburg, Alexandr L.
Publicado 2022